Radiosensitivity and response to 5-fluorouracil and irinotecan in the mouse xenografts, however, was able to be restored by the re-expression of SPARC, while the overexpression of SPARC in CRC xenografts enhanced tumour sensitivity to radiation and chemotherapy[33]. The gene discussed is SPARC; the disease is neoplasm.